Decipher Labs Quarterly Results
Decipher Labs quarterly results. In Mar 2026, Decipher Labs (DECIPHER) reported revenue ₹4 Cr and net profit ₹0 Cr. Check Decipher Labs market cap to track the company's total market size over time.
DECIPHER Quarterly Results — Revenue, Profit & EPS Highlights
Decipher Labs latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review DECIPHER PE ratio trends to evaluate earnings-based valuation against sector peers.
- Revenue of ₹4 Cr in Mar 2026 (+33.3% vs Jun 2026, +0.0% vs Mar 2025)
- Operating Margin of 6.0% in Mar 2026 (+96.0pp vs Jun 2026)
- Earnings Per Share of ₹-0.35 in Mar 2026 (+83.8% vs Jun 2026)
Decipher Labs Quarterly Results — Revenue, EBITDA, Net Profit & EPS
DECIPHER quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 4 | 3 | 4 | 4 | 3 | 33.3% | - |
| Net Profit (₹ Cr) | 0 | -2 | 0 | -4 | -3 | - | - |
| EBITDA (₹ Cr) | 0 | -2 | 0 | -6 | -3 | - | - |
| EPS (₹) | -0.35 | -2.16 | 0.02 | -4.07 | -3.39 | - | - |
| Operating Margin (%) | 6.0% | -90.0% | 3.0% | -188.0% | -114.0% | - | - |
DECIPHER Share Price Trend — 1-Year Movement Across Quarterly Results
Decipher Labs 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit DECIPHER share price.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
DECIPHER vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Decipher Labs latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹421,995.00 Cr | 1743.0 | 15,018 | 2,710 | -5.6% | - | 18.0% | 154.2 |
|
Divis Laboratories
Mar 2026 |
₹250,230.68 Cr | 9087.0 | 2,986 | 751 | -5.0% | - | 25.2% | 321.0 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4558.7 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 396.1 |
|
Zydus Life Science
Mar 2026 |
₹111,111.95 Cr | 1113.9 | 7,569 | 1,341 | -4.3% | - | 17.7% | 88.1 |
|
Laurus Labs
Mar 2026 |
₹110,537.07 Cr | 2069.0 | 1,823 | 282 | -10.5% | - | 15.5% | 400.2 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores